TOMM70 and breast cancer: Richter et al. identified TOM70 as the primary target of RL2 in the mitochondrial membrane and proved that RL2 acts primarily on the mitochondria, causing reduced ATP generation and apoptosis in breast cancer (Richter et al., 2020).